Zhejiang Orient Gene Biotech Co Ltd (688298) — Free Cash Flow Generation Index

Latest as of September 2022: 0.61x

Zhejiang Orient Gene Biotech Co Ltd (688298) has a Free Cash Flow Generation Index of 0.61x as of September 2022. Free cash flow of CN¥190.31 Million represents 1% of operating cash flow (CN¥309.89 Million). See 688298 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.61x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥190.31 Million
CNY

Operating Cash Flow

CN¥309.89 Million
CNY

Capital Expenditures

CN¥119.58 Million
CNY

Zhejiang Orient Gene Biotech Co Ltd Free Cash Flow Generation Index (2016–2022)

Historical FCF Generation Index trend for Zhejiang Orient Gene Biotech Co Ltd across 7 annual periods. Explore 688298 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Zhejiang Orient Gene Biotech Co Ltd (2016–2022)

Year-by-year Free Cash Flow Generation Index for Zhejiang Orient Gene Biotech Co Ltd. For the full company profile including market capitalisation, see market value of Zhejiang Orient Gene Biotech Co Ltd.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.65x CN¥1.94 Billion CN¥3.00 Billion CN¥1.05 Billion ▼ -28.1%
2021 0.90x CN¥4.70 Billion CN¥5.20 Billion CN¥507.87 Million ▼ -2.9%
2020 0.93x CN¥1.66 Billion CN¥1.79 Billion CN¥126.93 Million ▲ +19.0%
2019 0.78x CN¥42.31 Million CN¥54.21 Million CN¥11.90 Million ▲ +35.9%
2018 0.57x CN¥25.45 Million CN¥44.33 Million CN¥18.88 Million ▼ -4.5%
2017 0.60x CN¥20.16 Million CN¥33.54 Million CN¥13.38 Million ▼ -0.8%
2016 0.61x CN¥7.16 Million CN¥11.81 Million CN¥4.65 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).